DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Isshiki T, Kimura T, Ogawa H. , et al; PRASFIT-Elective Investigators.
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Circ J 2014;
78 (12) 2926-2934
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.